Clinical trials
Hospitalized Patients clinical trials
Below are recruiting hospitalized patients clinical trials, each written for real people, not researchers. We’re tracking 3,592 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07470502Recruiting
Study of infliximab for children and teens with IBD
This trial is looking at children and teenagers with Crohn's disease or ulcerative colitis who are starting a biologic medicine called infliximab. It aims to learn more about how this treatment works in young patients.
Florence, ItalyAges 3–18 - NCT07474142Recruiting
PSMA PET scan for newly diagnosed prostate cancer
This study looks at whether a special scan called PSMA PET can help predict how prostate cancer will progress. It is for people who have just been diagnosed and have not started treatment yet.
Lanzhou, GansuAges 18–100 - NCT07477522RecruitingPhase 1
High-fiber diet study for solid tumor patients
This trial tests whether eating a high-fiber diet can improve your gut health, metabolism, and immune system. It is for people with solid tumors who are able to eat or use a feeding tube.
Chengdu, SichuanAges 18–75 - NCT07482020RecruitingPhase 2
SGLT2 inhibitor for atrial fibrillation, high blood pressure, and high blood sugar
This study tests whether a medication called an SGLT2 inhibitor (a type of diabetes drug) can improve the function of the upper left heart chamber in people who have paroxysmal atrial fibrillation, high blood pressure, and abnormal blood sugar levels. If you qualify, the trial may help your heart work better and reduce your risk of stroke.
Shanghai, Shanghai MunicipalityAges 18–80 - NCT07487480Recruiting
Guselkumab for Crohn's after ustekinumab
This study looks at whether guselkumab, a different biologic medicine, can help people with Crohn's disease who have already tried ustekinumab but it didn't work well or caused side effects. It aims to see if switching to guselkumab is safe and effective.
Hangzhou, ZhejiangAges 18–75 - NCT07487610Recruiting
Pain and health in adults 80 and older
This study looks at the link between nerve pain (neuropathic pain) and overall health in people aged 80 and older. It aims to understand how pain affects daily life and aging.
EdirneAges 80 years+ - NCT07500753Recruiting
Study of a conditioning regimen for older adults with hard-to-treat leukemia or MDS
This trial tests a chemotherapy combination (Clad-LABU) to prepare older patients for a stem cell transplant. It is for people aged 50 or older with relapsed or refractory AML or high-risk MDS.
Suzhou, JiangsuAges 50 years+ - NCT07508410Recruiting
Mulligan vs Myofascial Release for Neck-Related Headaches
This study compares two hands-on therapy techniques—Mulligan mobilization and myofascial release—to see which works better for headaches that start from the neck. If you have neck pain on one side and headaches that get worse with movement, this trial may help you find relief.
KonyaAges 18–65 - NCT07531810Recruiting
Nose Surgery Recovery and Patient Satisfaction Study
This study tracks how patients feel and function after nose surgery that uses a piece of cartilage (septal extension graft) to reshape the nose. Researchers want to understand both the benefits and any complications to improve future care.
Sivas, SivasAges 18 years+ - NCT07590310RecruitingEarly Phase 1
CAIX-Targeted PET Imaging Scan for Tumor Diagnosis
This early-stage trial tests a new type of imaging scan (called PET) that uses a special tracer to help doctors see tumors better. The scan targets a protein called CAIX that appears on many cancer cells, which may help with accurate diagnosis and staging.
Beijing, HaidianAges 18–75 - NCT07633483Recruiting
Anxiety and Frailty in Older Adults Having Hip Replacement
This study watches how nervous patients feel before hip replacement surgery and how that connects to their overall strength and ability to bounce back. Researchers want to understand whether anxiety levels and frailty affect each other in older adults.
Istanbul, IstanbulAges 65 years+ - NCT06641193Enrolling by invitation
rTMS for arm slowness in early Parkinson's
This trial tests a brain stimulation technique called rTMS to see if it can help improve slowness of movement in the arm and hand. It's for people with early-stage Parkinson's whose symptoms started on the left side and whose main problem is moving slowly.
Shanghai, ChinaAges 50–75 - NCT06510634Enrolling by invitation
Stroke treatment after 24 hours for vertebrobasilar blockage
This trial tests a method to triage people who had a stroke in the back part of the brain (vertebrobasilar artery) more than 24 hours ago. The goal is to find the best way to decide which patients may still benefit from treatment.
Tianjin, Tianjin MunicipalityAges 18–90 - NCT05690191Enrolling by invitation
Chidamide treatment for returning or hard-to-treat lymphoma
This trial studies chidamide (a prescription medicine) in people with diffuse large B-cell lymphoma that has come back or did not respond to at least one prior treatment. It may help shrink tumors and improve disease control for eligible patients.
Suzhou, JiangsuAges 18 years+ - NCT03459820Enrolling by invitationPhase 2/Phase 3
PET/CT scan study for high-risk or returning prostate cancer
This trial studies how a special PET/CT scan (using 18F-DCFPyL) helps evaluate prostate cancer that is either high-risk at diagnosis or has come back based on PSA blood tests. It may help your care team better stage (map) the cancer and guide next steps.
Montreal, QuebecAges 18 years+ - NCT06134492RecruitingPhase 3
Acyclovir for pneumonia patients with HSV-1 on breathing support
This trial tests whether acyclovir, an antiviral drug, can help patients with pneumonia who are on breathing support and have herpes simplex virus in their lung fluid. The goal is to see if it improves recovery.
Freiburg im Breisgau, Baden-WurttembergAges 18 years+ - NCT06958627RecruitingPhase 2/Phase 3
Smart phone app vs standard care for breast cancer treatment
This trial tests whether a smartphone-based patient management program helps women with HER2-positive breast cancer take their medication (pyrotinib) more consistently compared to usual care. It may be a good fit if you are starting or continuing pyrotinib treatment.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06098430Recruiting
Quality of life in NLPHL patients
This study looks at how people with a rare type of Hodgkin lymphoma (NLPHL) feel about their health and quality of life. By filling out surveys, you can help doctors understand what really matters to patients like you.
Palo Alto, CaliforniaAges 8 years+ - NCT07525986RecruitingPhase 4
Pain control after laparoscopic colon surgery using a button-press system
This trial tests a new pain medication (anrikefon) that patients can control themselves by pressing a button after laparoscopic colon surgery. The goal is to see if it works better or safer than standard pain relief, especially for patients whose nerve blocks alone don't fully control pain.
Beijing, Beijing MunicipalityAges 18–75 - NCT07587294Recruiting
Ultrasound Treatment to Prevent Heart Rhythm Problems After Heart Attack
This trial tests whether a special ultrasound procedure on the side of your neck can help prevent dangerous irregular heartbeats in patients who recently had a heart attack treated with a stent. The goal is to see if this treatment is safe and effective.
Huangshi, HubeiAges 18–80 - NCT06814223RecruitingPhase 4
Can antibiotics prevent catheter infections in dialysis patients?
This study tests if giving antibiotics before placing a dialysis catheter can prevent infections. It may help people with heart conditions or those who need a catheter in the leg.
Nahariya, IsraelAges 18 years+ - NCT07798778RecruitingEarly Phase 1
New drug for advanced prostate cancer that has stopped responding to hormone therapy
This trial tests a new drug called SRT-017 for men with advanced prostate cancer that has stopped responding to standard hormone therapy. The drug targets a marker on cancer cells (PSMA) and may help slow the disease. The study will check if it is safe and effective.
Wuxi, JiangsuAges 18 years+ - NCT07069959Recruiting
Measuring leg muscle recovery after ICU breathing support
This study checks how leg muscles recover after being in the ICU on a breathing machine. It uses a strength test and a special ultrasound to measure muscle health.
Nantes, Loire AtlantiqueAges 18 years+ - NCT07347990Recruiting
Iptacopan for high-risk TA-TMA after stem cell transplant
This trial tests a new oral medicine called iptacopan for people who have a serious blood vessel complication after a stem cell transplant (TA-TMA) that is not improving with usual treatments. The goal is to see if iptacopan can help stop the damage and improve recovery.
Hangzhou, ChinaAges 12 years+
Hear when a new Hospitalized Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalized patients?
- Yes. Clin2 currently lists 3,592 recruiting hospitalized patients studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalized patients trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalized patients trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.